Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDCN researchers lead a global study based on analysing survey data

Close up of hands of two people working at desk with laptops and papers

Dr Arjune Sen heads up the Oxford Epilepsy Research Group. In partnership with local charity SUDEP Action, he will lead a project to investigate how COVID-19 has impacted on people with epilepsy, their carers and health care workers. In particular, they are interested in assessing escalation and mitigation of risk.

The team will be addressing this question using data from across the globe. They will employ surveys using the online JISC platform - pilot surveys are currently being reviewed and translated into multiple languages. The data will be entered anonymously and analysed in aggregated. It is hoped that as many as 500 participants will be engaged.

The aim is to use the findings to make specific recommendations on how to manage risk in people with epilepsy during the coronavirus pandemic and beyond. The team will highlight challenges and opportunities in a global context which can inform and improve patient care and help save lives.

Initially this work will be funded by the Oxfordshire Biomedical Research Centre and SUDEP Action. Collaborators include University College London and Professor Charles Newton from the Department of Psychiatry at the University of Oxford.

 

 

Similar stories

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Meeting the neuroscientists at Meeting Minds

Ben Seymour and Masud Husain joined the line up of speakers at this year's Meeting Minds event for Oxford alumni on 19 September

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.